Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLUCOSE-in-PN
NCT02216799Phase 4Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Mar 2013
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine in diabetes mellitus (DM) (2 arms), sponsored by King Faisal Specialist Hospital and Research Centre. Primary endpoint: Achievement of target blood glucose (140 mg/dL to 200 mg/dL) at 2 years. Started Mar 2013; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02216799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216799.